首页 | 官方网站   微博 | 高级检索  
     

舒林酸对卵巢癌细胞系CP70顺铂耐药性的逆转作用
引用本文:邵娟,辛晓燕,魏燕,段海霞.舒林酸对卵巢癌细胞系CP70顺铂耐药性的逆转作用[J].陕西肿瘤医学,2011(2):208-211.
作者姓名:邵娟  辛晓燕  魏燕  段海霞
作者单位:第四军医大学西京医院妇产科,陕西西安710032
摘    要:目的:研究舒林酸体外逆转卵巢癌细胞系CP70的顺铂耐药性,并探讨其与β—catenin表达的关系。方法:MTT法检测单独使用舒林酸或顺铂及两药联合使用时对CP70细胞的抑制作用,免疫细胞化学和Westernblot方法检测细胞内β—catenin表达水平。结果:两药联合处理细胞后顺铂耐药逆转倍数为6.01,联合处理组的细胞中β—catenin表达明显降低。结论:舒林酸能部分逆转CP70细胞对顺铂的耐药性,且此作用可能与下调细胞的β—catenin表达有关。

关 键 词:舒林酸  卵巢癌  顺铂  耐药性

Sulindac resensitizes cisplatin -resistant human ovarian cancer cells CP70
Affiliation:SHAO Juan, XIN Xiao - yan, WEI Yan, DUAN Hai - xia (Oepartment of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.)
Abstract:Objective:To study the effect of sulindac in resensitizing cisplatin - resistant human ovarian cancer cells CP70, and to discuss the related mechanism. Methods: MTF assay was used to assess the inhibitory effects of sulindae, cisplatin alone or a combination of both on CP70 cells. Immunohistochemical analysis and Western blotting were employed to observe the expression of β - catenin in different groups. Results: The resensitizing fold of cisplatin combined with sulindac was 6.01. The expression of β - catenin had the most prominent decrease in CP70 cells in the combination group. Conclusion: Sulindac can partially resensitize cisplatin -resistant CP70 cells,which might be related to the down - regulation of β- catenin.
Keywords:sulindac  ovarian cancer  cisplatin  drug resistance
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号